Cargando…
Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma
Background: Immunotherapy has become the new standard of care for recurrent and metastatic head and neck squamous cell carcinoma (HNSCC), and PD-L1 is a widely used biomarker for immunotherapeutic response. However, PD-L1 expression in most cancer patients is low, and alternative biomarkers used to...
Autores principales: | Zhu, Chunmei, Wu, Qiuji, Yang, Ningning, Zheng, Zhewen, Zhou, Fuxiang, Zhou, Yunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108548/ https://www.ncbi.nlm.nih.gov/pubmed/35586567 http://dx.doi.org/10.3389/fgene.2022.848841 |
Ejemplares similares
-
A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer
por: Zhu, Chunmei, et al.
Publicado: (2021) -
TYK2 correlates with immune infiltration: A prognostic marker for head and neck squamous cell carcinoma
por: He, Yaodong, et al.
Publicado: (2022) -
Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation
por: Feng, Yao, et al.
Publicado: (2023) -
A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yi, et al.
Publicado: (2021) -
A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration
por: Chi, Hao, et al.
Publicado: (2022)